Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Fully functional, naturally occurring and C-terminally truncated variant human immunodeficiency virus (HIV) Vif does not bind to HIV Gag but influences intermediate filament structure.

Henzler T, Harmache A, Herrmann H, Spring H, Suzan M, Audoly G, Panek T, Bosch V.

J Gen Virol. 2001 Mar;82(Pt 3):561-73.

PMID:
11172097
2.

Role of Vif in stability of the human immunodeficiency virus type 1 core.

Ohagen A, Gabuzda D.

J Virol. 2000 Dec;74(23):11055-66.

3.

Zinc finger structures in the human immunodeficiency virus type 1 nucleocapsid protein facilitate efficient minus- and plus-strand transfer.

Guo J, Wu T, Anderson J, Kane BF, Johnson DG, Gorelick RJ, Henderson LE, Levin JG.

J Virol. 2000 Oct;74(19):8980-8.

4.

Association of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcription.

Dettenhofer M, Cen S, Carlson BA, Kleiman L, Yu XF.

J Virol. 2000 Oct;74(19):8938-45.

8.

Association of Nef with the human immunodeficiency virus type 1 core.

Kotov A, Zhou J, Flicker P, Aiken C.

J Virol. 1999 Oct;73(10):8824-30.

9.
10.

Microtubule-dependent plus- and minus end-directed motilities are competing processes for nuclear targeting of adenovirus.

Suomalainen M, Nakano MY, Keller S, Boucke K, Stidwill RP, Greber UF.

J Cell Biol. 1999 Feb 22;144(4):657-72.

11.
12.

Evidence for a newly discovered cellular anti-HIV-1 phenotype.

Simon JH, Gaddis NC, Fouchier RA, Malim MH.

Nat Med. 1998 Dec;4(12):1397-400.

PMID:
9846577
14.
15.

High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells.

Mochizuki H, Schwartz JP, Tanaka K, Brady RO, Reiser J.

J Virol. 1998 Nov;72(11):8873-83.

17.

The replicative impairment of Vif- mutants of human immunodeficiency virus type 1 correlates with an overall defect in viral DNA synthesis.

Nascimbeni M, Bouyac M, Rey F, Spire B, Clavel F.

J Gen Virol. 1998 Aug;79 ( Pt 8):1945-50.

PMID:
9714242
18.

Characterization of highly purified, inactivated HIV-1 particles isolated by anion exchange chromatography.

Richieri SP, Bartholomew R, Aloia RC, Savary J, Gore R, Holt J, Ferre F, Musil R, Tian HR, Trauger R, Lowry P, Jensen F, Carlo DJ, Maigetter RZ, Prior CP.

Vaccine. 1998 Jan-Feb;16(2-3):119-29.

PMID:
9607019
19.

Interaction and co-encapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins.

Huvent I, Hong SS, Fournier C, Gay B, Tournier J, Carrière C, Courcoul M, Vigne R, Spire B, Boulanger P.

J Gen Virol. 1998 May;79 ( Pt 5):1069-81.

PMID:
9603321
20.
Items per page

Supplemental Content

Support Center